Skip to main content
Johanna C. Purdy
No Rating Available
(Learn About Our Rating System)

Johanna C. Purdy, MD

Languages spoken: Spanish, English

Board Certification

American Board of Internal Medicine (Internal Medicine)

Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor (Clinical)
Academic Divisions General Medicine
Board Certification
American Board of Internal Medicine (Internal Medicine)

Education history

Undergraduate Biology - University of Utah B.Sc. (Hons)
Professional Medical Medicine - University of Utah School of Medicine M.D.
Residency Internal Medicine - Oregon Health & Science University Resident

Selected Publications

Journal Article

  1. Salas A, Boanca K, Purdy J, De Lima B, Peterson M, Nerness R, Eckstrom E, Kwon (2024). Resident-led research: A quality improvement project to improve serious illness conversations. Gerontology & geriatrics education, 45(4), 499-504.
  2. Bohn JA, Kassaye BM, Record D, Chou BC, Kraft IL, Purdy JC, Hilton KA, Miller DA, Getachew S, Addissie A, Robison JA (2016). Demographic and mortality analysis of hospitalized children at a referral hospital in Addis Ababa, Ethiopia. BMC Pediatr, 16(1), 168.
  3. Zabriskie MS, Eide CA, Tantravahi SK, Vellore NA, Estrada J, Nicolini FE, Khoury HJ, Larson RA, Konopleva M, Cortes JE, Kantarjian H, Jabbour EJ, Kornblau SM, Lipton JH, Rea D, Stenke L, Barbany G, Lange T, Hernández-Boluda JC, Ossenkoppele GJ, Press RD, Chuah C, Goldberg SL, Wetzler M, Mahon FX, Etienne G, Baccarani M, Soverini S, Rosti G, Rousselot P, Friedman R, Deininger M, Reynolds KR, Heaton WL, Eiring AM, Pomicter AD, Khorashad JS, Kelley TW, Baron R, Druker BJ, Deininger MW, O'Hare T (2014). BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia. Cancer Cell, 26(3), 428-442.
  4. Khorashad JS, Kelley TW, Szankasi P, Mason CC, Soverini S, Adrian LT, Eide CA, Zabriskie MS, Lange T, Estrada JC, Pomicter AD, Eiring AM, Kraft IL, Anderson DJ, Gu Z, Alikian M, Reid AG, Foroni L, Marin D, Druker BJ, O'Hare T, Deininger MW (2013). BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships. Blood, 121(3), 489-98.

Review

  1. Purdy JC, Shatzel JJ (2021). The hematologic consequences of obesity. [Review]. Eur J Haematol, 106, (3), 306-319.

Letter

  1. Purdy JC (2020). One More Question. [Letter to the editor]. Acad Med, 95(6), 823.